Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass

Minerva Anestesiologica

Volumn 76, Issue 8, 2010, Pages 584-591

  Choi, Y S ^a   Shim, J K ^a   Hong, S W ^b   Kim, J C ^a   Kwak, Y L ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Blood coagulation; Cardiopulmonary bypass; Postoperative hemorrhage

Indexed keywords

HETASTARCH; HUMAN ALBUMIN; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG SOLUTION; FEMALE; FIBRIN CLOT; HEART VALVE SURGERY; HEMOGLOBIN DETERMINATION; HUMAN; INFLAMMATION; MALE; MITRAL VALVE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; UPREGULATION;

BLOOD COAGULATION; CARDIOPULMONARY BYPASS; FEMALE; GLYCOPROTEINS; HEART VALVE DISEASES; HETASTARCH; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MITRAL VALVE; PLASMA SUBSTITUTES; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 77954961425     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001;15:316-21.
2. Van der Linden PJ, De Hert SG, Daper A, Trenchant A, Schmartz D, Defrance P et al. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth 2004;51:236-41.
3. Horstick G, Lauterbach M, Kempf T, Bhakdi S, Heimann A, Horstick M et al. Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock. Crit Care Med 2002;30:851-5.
4. Rhee P, Wang D, Ruff P, Austin B, DeBraux S, Wolcott K et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 2000;28:74-8.
5. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001;72:527-34.
6. Haynes GR, Navickis RJ, Wilkes MM. Albumin administration-what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 2003;20:771-93.
7. Ranucci M, Balduini A, Ditta A, Boncilli A, Brozzi S. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg 2009;87:1311-9.
8. Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 1993;76:1185-90.
9. Kasper SM, Meinert P, Kampe S, Görg C, Geisen C, Mehlhorn U et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 2003;99:42-7.
10. Boldt J, Brosch C, Rohm K, Lehmann A, Mengistu A, Suttner S. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg 2008;107:1496-503.
11. Hanart C, Khalife M, De Ville A, Otte F, De Hert S, Van der Linden P. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 2009;37:696-701.
12. Ranucci M. The endothelial function in cardiac surgery. Minerva Anestesiol 2006;72:503-6.
13. Kuitunen AH, Heikkila LJ, Salmenpera MT. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation. Ann Thorac Surg 1997;63:438-44.
14. Tigchelaar I, Gallandat Huet RC, Korsten J, Boonstra PW, van Oeveren W. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg 1997;11:626-32.
15. London MJ, Franks M, Verrier ED, Merrick SH, Levin J, Mangano DT. The safety and efficacy of ten percent pen-tastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial. J Thorac Cardiovasc Surg 1992;104:284-96.
16. McCammon AT, Wright JP, Figueroa M, Nielsen VG. Hemodilution with albumin, but not Hextend, results in hypercoagulability as assessed by Thrombelastography in rabbits: role of heparin-dependent serpins and factor VIII complex. Anesth Analg 2002;95:844-50.
17. Adrian K, Mellgren K, Skogby M, Friberg LG, Mellgren G, Wadenvik H. The effect of albumin priming solution on platelet activation during experimental long-term perfusion. Perfusion 1998;13:187-91.
18. Boldt J, Zickmann B, Ballesteros BM, Stertmann F, Hempelmann G. Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. Anesth Analg 1992;74:219-25.
19. Pulimood TB, Park GR. Debate: Albumin administration should be avoided in the critically ill. Crit Care 2000;4:151-5.
20. Boldt J, Scholhorn T, Mayer J, Piper S, Suttner S. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery. Anesth Analg 2006; 103: 191-9.
21. Schortgen F, Deye N, Brochard L. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 2004;30:2222-9.
22. Cope JT, Banks D, Mauney MC, Lucktong T, Shockey KS, Kron IL et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg 1997;63:78-83.
23. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654-60.
24. Haas T, Preinreich A, Oswald E, Pajk W, Berger J, Kuehbacher G et al. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia 2007;62:1000-7.
25. Egli GA, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 1997;78:684-9.
26. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005;49:373-8.
27. Tokunaga C, Bateman RM, Boyd J, Wang Y, Russell JA, Walley KR. Albumin resuscitation improves ventricular contractility and myocardial tissue oxygenation in rat endotoxemia. Crit Care Med 2007;35:1341-7.
28. Celik JB, Gormus N, Okesli S, Gormus ZI, Solak H. Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: effects on TNF-alpha, IL-6, IL-8, IL-10. Perfusion 2004;19:185-91.
29. Boldt J, Brosch C, Rohm K, Papsdorf M, Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 2008;100:457-64.
30. Feng X, Yan W, Wang Z, Liu J, Yu M, Zhu S et al. Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage. Anesth Analg 2007;104:624-30.